Lexology April 11, 2022
Proskauer Rose LLP

Contingency management (CM) is a form of intervention treatment program that incentivizes patients with substance use disorders to observe certain conditions—such as non-use of drugs or alcohol confirmed via urine drug screening or breathalyzer test, or even drug therapy adherence—in exchange for something of monetary value. Adherence is often tracked and confirmed by those that provide the incentive payment through digital health technologies—including apps that can be downloaded to the patient’s smart phone or that are already downloaded to a smart phone provided to the patient as part of a CM program. While many contend that CM is an effective, evidence-based treatment, certain legal barriers limit, and often prevent, its widespread adoption and use. When there is the potential for...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, OIG, Patient / Consumer, Provider, Technology
Finding Balance in a Digital World
Five from ViVE: Takeaways from the digital health conference
Finally A Good Wearable Blood Pressure Monitor: Aktiia Bracelet Review - 2
Top 18 Technologies For The Aging Populations - 2
The distressed HealthTech M&A landscape in 2025

Share This Article